Reduction of withdrawal signs after chronic nicotine exposure of alpha-calcitonin gene-related peptide knock-out mice

Neuroscience Letters

Volumn 360, Issue 1-2, 2004, Pages 73-76

  Salmon, Anne Marie ^a   Evrard, Alexis ^a   Damaj, Imad ^a   Changeux, Jean Pierre ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Acute or chronic tolerance; Alpha calcitonin gene related peptide; Dependence; Nicotine; Oral administration

Indexed keywords

ALPHA CALCITONIN GENE RELATED PEPTIDE;

ADDICTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BRAIN REGION; CONTROLLED STUDY; EXPERIMENTAL ANIMAL; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NICOTINE; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 1842663264     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.02.031     Document Type: Article

References (20)

1. Clarke P.B.S. The mesolimbic dopamine system as a target for nicotine. Adlkofer F., Thurau K. Effects of Nicotine on Biological Systems. 1991;285-294 Birkäuser Verlag, Basel.
2. Corigall W.A., Coen K.M. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology. 99:1989;473-478.
3. Domino E.F. Tobacco smoking and nicotine neuropsychopharmacology: some future research directions. Neuropsychopharmacology. 18:1997;456-468.
4. 2+ in rat chromaffin cells in vitro. J. Neurosci. 19:(8):1999;2945-2953.
5. Hökfelt T., Arvidsson U., Ceccatelli S., Cortés R., Cullheim S., Dagerlind A., Johnson H., Orazzo C., Piehl F., Pieribone V., Schalling M., Terenius L., Ulfhake B., Verge V.M., Villar M., Wiesenfeld-Hallin Z., Xu X.J., Xu Z. Calcitonin gene-related peptide in the brain, spinal cord, and some peripheral systems. Ann. N. Y. Acad. Sci. 657:1992;119-134.
6. Le Novère N., Corringer P.J., Changeux J.P. The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. J. Neurobiol. 53:2002;447-456.
7. Malin D.H., Lake J.R., Carter V.A., Cunningham J.S., Wilson O.B. Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology. 115:1993;180-184.
8. Malin D.H. Nicotine dependence: studies with a laboratory model. Pharmacol. Biochem. Behav. 70:2001;551-559.
9. Mulle C., Benoit P., Pinset C., Roa M., Changeux J.P. Calcitonin gene-related peptide enhances the rate of desensitization of the nicotinic acetylcholine receptor in cultured mouse muscle cells. Proc. Natl. Acad. Sci. USA. 85:1988;5728-5732.
10. Orazzo C., Pieribone V.A., Cecatelli S., Terenius L., Hökfelt T. CGRP-like immunoreactivity in A11 dopamine neurons projecting to the spinal cord and a note on CGRP-CCK cross-reactivity. Brain Res. 600:(1):1993;39-48.
11. Pekonen K., Karlsson C., Laakso I., Ahtee L. Plasma nicotine and cotinine concentrations in mice alter chronic oral nicotine administration and challenge doses. Eur. J. Pharm. Sci. 1:1993;13-18.
12. Perry D.C., Davila-Garcia M.I., Stockmeir C.A., Kellar K.J. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J. Pharmacol. Exp. Ther. 289:(3):1999;1545-1552.
13. Picciotto M.R., Zoli M., Rimondini R., Lena C., Marubio L.M., Merlo-Pich E., Fuxe K., Changeux J.P. Acetylcholine receptors containing the beta2-subunit are involved in the reinforcing properties of nicotine. Nature. 391:1998;173-177.
14. Pietilä K., Lädhe T., Attila M., Ahtee L., Nordberg A. Regulation of nicotinic receptors in the brain of mice withdrawn from chronic oral nicotine treatment. Naunyn-Schmiedeberg's Arch. Pharmacol. 357:1998;176-182.
15. Salmon A.M., Damaj M.I., Sekine S., Picciotto M.R., Marubio L.M., Changeux J.P. Modulation of morphine analgesia in alphaCGRP mutant mice. NeuroReport. 10:1999;849-854.
16. Salmon A.M., Damaj M.I., Marubio L.M., Epping-Jordan M., Merlo-Pich E., Changeux J.P. Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in alphaCGRP-deficient mice. Nat. Neurosci. 4:2001;357-358.
17. Stolerman I.P., Fink R., Jarvik M.E. Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacologia. 30:1974;329-342.
18. Stolerman I.P., Shoaib M. The neurobiology of tobacco addiction. Trends Pharmacol. Sci. 12:1991;467-473.
19. Watkins S.S., Koob G.F., Markou A. Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tobacco Res. 2:2000;19-37.
20. Zarrindast D.R., Farzin D. Nicotine attenuates naloxone-induced jumping behavior in morphine-dependent mice. Eur. J. Pharmacol. 298:(1):1996;1-6.